%0 Interview
%T First person profile: Dr Carl June: Dr June recently participated on a panel with the FDA to discuss the next steps needed to expand CAR T-cell therapy into areas other than blood cancers.
%A Nierengarten MB
%J Cancer
%V 130
%N 14
%D 2024 Jul 15
%M 38943467
%F 6.921
%R 10.1002/cncr.35420